Adverum Biotechnologies Inc (ADVM) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Mon June 7th, 2021

- 14:00
  AnalysisWhy Adverum Biotechnologies Stock Sank in MayThe Motley Fool

Wed May 12th, 2021

- 12:00
  AnalysisRegenxbio: Better Investment Case Than AdverumSeeking Alpha

Tue May 11th, 2021

- 09:00
  Press ReleasesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVMPR Newswire

Wed May 5th, 2021

- 15:05
  AnalysisAdverum Biotechnologies: An Uncertain Path ForwardSeeking Alpha + 1 more

Mon May 3rd, 2021

- 11:27
  AnalysisAdverum Biotechnologies: One Adverse Event Too ManySeeking Alpha

Thu April 29th, 2021

- 15:48
  AnalysisWhy Adverum Biotechnologies Stock Is Imploding TodayThe Motley Fool

Thu April 22nd, 2021

- 15:04
  AnalysisOcular Therapeutix: Good Medicine, High CompetitionSeeking Alpha

Thu April 8th, 2021

- 13:39
  Press ReleasesThe Sonic Fund II, L.P. Files Preliminary Proxy Statement Relating to the Election of Highly Qualified Independent Directors at the 2021 Annual Meeting of Adverum Biotechnologies, Inc.PR Newswire

Mon March 15th, 2021

- 13:46
  AnalysisKodiak Sciences Offers Multiple Shots On Goal For Eye Treatments, Multiple Catalysts Expected In 2022Seeking Alpha

Wed March 3rd, 2021

- 20:52
  EarningsAnalysisAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationSeeking Alpha

Tue March 2nd, 2021

- 12:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 04:24
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon January 25th, 2021

- 11:46
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisInsider Weekends: Insiders Of Driven Brands Driven To Buy MoreSeeking Alpha

Mon January 11th, 2021

- 00:16
  AnalysisAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketSeeking Alpha

Mon December 21st, 2020

- 17:47
  AnalysisPharming Group Lines Up U.S. Offering PlanSeeking Alpha

Tue October 6th, 2020

- 17:48
  AnalysisGene Therapy Stocks - A Buying OpportunitySeeking Alpha

Tue September 29th, 2020

- 17:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideAssessing AdverumSeeking Alpha

Wed August 12th, 2020

- 16:50
  AnalysisEquillium Jumps On Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Tue August 11th, 2020

Fri June 26th, 2020

- 21:52
  RatingAdverum Biotechnologies downgraded to umderperform from market perform at Raymond JamesMarketWatch

Fri June 12th, 2020

- 20:40
  AnalysisAdverum Biotechnologies (ADVM) Investor Presentation - SlideshowSeeking Alpha

Fri May 29th, 2020

Thu May 28th, 2020

- 23:06
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAdverum Biotechnologies, Inc. 2020 Q1 - Results - Earnings Call PresentationSeeking Alpha

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

NVAX$173.01-3.8%

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

NVAX$173.01-3.8%

About Developer Contact